###begin article-title 0
Lung epithelial apoptosis in influenza virus pneumonia: the role of macrophage-expressed TNF-related apoptosis-inducing ligand
###end article-title 0
###begin p 1
###xml 31 71 31 71 <email xmlns:xlink="http://www.w3.org/1999/xlink">Susanne.Herold@innere.med.uni-giessen.de</email>
CORRESPONDENCE Susanne Herold: Susanne.Herold@innere.med.uni-giessen.de
###end p 1
###begin p 2
This article is distributed under the terms of an Attribution-Noncommercial-Share Alike-No Mirror Sites license for the first six months after the publication date (see ). After six months it is available under a Creative Commons License (Attribution-Noncommercial-Share Alike 3.0 Unported license, as described at ).
###end p 2
###begin p 3
###xml 515 518 515 518 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 425 431 <span type="species:ncbi:10090">murine</span>
###xml 520 524 <span type="species:ncbi:10090">mice</span>
###xml 704 708 <span type="species:ncbi:10090">mice</span>
Mononuclear phagocytes have been attributed a crucial role in the host defense toward influenza virus (IV), but their contribution to influenza-induced lung failure is incompletely understood. We demonstrate for the first time that lung-recruited "exudate" macrophages significantly contribute to alveolar epithelial cell (AEC) apoptosis by the release of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) in a murine model of influenza-induced pneumonia. Using CC-chemokine receptor 2-deficient (CCR2-/-) mice characterized by defective inflammatory macrophage recruitment, and blocking anti-CCR2 antibodies, we show that exudate macrophage accumulation in the lungs of influenza-infected mice is associated with pronounced AEC apoptosis and increased lung leakage and mortality. Among several proapoptotic mediators analyzed, TRAIL messenger RNA was found to be markedly up-regulated in alveolar exudate macrophages as compared with peripheral blood monocytes. Moreover, among the different alveolar-recruited leukocyte subsets, TRAIL protein was predominantly expressed on macrophages. Finally, abrogation of TRAIL signaling in exudate macrophages resulted in significantly reduced AEC apoptosis, attenuated lung leakage, and increased survival upon IV infection. Collectively, these findings demonstrate a key role for exudate macrophages in the induction of alveolar leakage and mortality in IV pneumonia. Epithelial cell apoptosis induced by TRAIL-expressing macrophages is identified as a major underlying mechanism.
###end p 3
###begin p 4
Abbreviations used: AEC, alveolar epithelial cell; BAL, bronchoalveolar lavage; BALF, BAL fluid; CCL2, CC-chemokine ligand 2; CCR2, CC-chemokine receptor 2; FasL, Fas ligand; IV, influenza virus; mRNA, messenger RNA; pi, post infection; TRAIL, TNF-related apoptosis-inducing ligand.
###end p 4
###begin p 5
###xml 456 457 456 457 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib1">1</xref>
###xml 573 574 573 574 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 579 583 579 583 <sup xmlns:xlink="http://www.w3.org/1999/xlink">high</sup>
###xml 588 591 588 591 <sup xmlns:xlink="http://www.w3.org/1999/xlink">low</sup>
###xml 617 618 617 618 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 623 627 623 627 <sup xmlns:xlink="http://www.w3.org/1999/xlink">high</sup>
###xml 632 636 632 636 <sup xmlns:xlink="http://www.w3.org/1999/xlink">high</sup>
###xml 680 681 680 681 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib2">2</xref>
###xml 683 684 683 684 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib3">3</xref>
###xml 761 764 761 764 <sup xmlns:xlink="http://www.w3.org/1999/xlink">int</sup>
###xml 769 770 769 770 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 775 776 775 776 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</sup>
###xml 781 782 781 782 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 787 788 787 788 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 1013 1014 1013 1014 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib1">1</xref>
###xml 1016 1017 1016 1017 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib4">4</xref>
###xml 1018 1019 1018 1019 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib6">6</xref>
###xml 1183 1184 1183 1184 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib7">7</xref>
###xml 61 67 <span type="species:ncbi:9606">humans</span>
Influenza viruses (IVs) may cause primary viral pneumonia in humans with fatal outcome as soon as the pathogen spreads from the upper respiratory tract to the alveolar air space, especially during infections with highly pathogenic IV. Early innate immune responses initiate the release of proinflammatory chemokines and the recruitment of neutrophils, lymphocytes, and particularly mononuclear phagocytes into the alveolar air space to limit viral spread (1). The mononuclear phagocyte system of the lung is composed of resident interstitial and alveolar macrophages (F4/80+CD11chighMHCIIlow) and pulmonary DCs (F4/80+CD11chighMHCIIhigh), both derived from a common BM precursor (2, 3). During lung inflammation and IV infection, peripheral blood monocytes (GR1intF4/80+CD11c-CD11b+CD115+) are recruited to the alveolar compartment of the lung via the interaction of CC-chemokine ligand 2 (CCL2), which is released from alveolar epithelial cells (AECs) with its monocytic receptor CC-chemokine receptor 2 (CCR2) (1, 4-6). These "exudate" macrophages acquire a lung resident macrophage phenotype and finally replenish the alveolar macrophage pool during the time course of infection (7).
###end p 5
###begin p 6
###xml 170 171 170 171 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib8">8</xref>
###xml 173 174 173 174 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib9">9</xref>
###xml 614 616 614 616 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib10">10</xref>
###xml 617 619 617 619 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib12">12</xref>
###xml 232 237 <span type="species:ncbi:9606">Human</span>
Besides their essential host defense functions, mononuclear phagocytes have been proposed to contribute to an imbalanced detrimental immune response during IV pneumonia (8, 9) and have been implicated in alveolar epithelial damage. Human IV pneumonia, which is characterized by rapid progression to lung failure and poor outcome, has gained in importance during the recent outbreaks in Southeast Asia. Infection with highly pathogenic IV causes significant tissue damage to the lungs with acute alveolitis followed by massive pulmonary edema and hemorrhage and extensive destruction of the respiratory epithelium (10-12). However, the distinct molecular steps of macrophage-epithelial interaction during IV-induced acute lung injury remain elusive.
###end p 6
###begin p 7
###xml 154 156 154 156 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib13">13</xref>
###xml 157 159 157 159 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib15">15</xref>
###xml 281 283 281 283 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib16">16</xref>
###xml 284 286 284 286 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib18">18</xref>
###xml 535 537 535 537 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib18">18</xref>
###xml 704 706 704 706 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib19">19</xref>
###xml 748 750 748 750 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib20">20</xref>
###xml 752 754 752 754 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib21">21</xref>
###xml 845 847 845 847 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib18">18</xref>
###xml 90 96 <span type="species:ncbi:10090">murine</span>
###xml 101 106 <span type="species:ncbi:9606">human</span>
###xml 620 626 <span type="species:ncbi:10090">murine</span>
###xml 805 811 <span type="species:ncbi:10090">murine</span>
Several authors suggest AEC apoptosis to be an underlying mechanism of alveolar damage in murine and human models of adult respiratory distress syndrome (13-15). Death receptors and their ligands play an important role in the orchestration of innate and adaptive immune responses (16-18). TNF-related apoptosis-inducing ligand (TRAIL) is a transmembrane protein belonging to the TNF superfamily. Among the members of this family, TRAIL exhibits the highest homology to Fas ligand (FasL), a well known inducer of programmed cell death (18). Being expressed mainly on T cells, NK cells, and mononuclear phagocyte subsets, murine TRAIL exerts its proapoptotic signals via binding to DR5 (death receptor 5) (19) and displays potent antitumor activity (20, 21). Recently, an antiviral function in experimental murine IV infection has been suggested (18). However, the contribution of TRAIL to alveolar epithelial apoptosis and lung barrier dysfunction during lethal IV pneumonia has not been elucidated yet.
###end p 7
###begin p 8
###xml 27 33 <span type="species:ncbi:10090">murine</span>
###xml 396 400 <span type="species:ncbi:10090">mice</span>
###xml 529 533 <span type="species:ncbi:10090">mice</span>
In the present study, in a murine model of IV-induced acute lung injury, we demonstrate for the first time that exudate macrophages recruited via the CCL2-CCR2 axis largely contribute to AEC apoptosis involving the expression of TRAIL. Both blockade of the specific chemokine-receptor axis and abrogation of macrophage TRAIL signaling by anti-TRAIL mAb treatment or use of adoptively transferred mice recruiting TRAIL-deficient exudate macrophages significantly reduced alveolar epithelial apoptosis and lung leakage in infected mice, resulting in increased survival during otherwise fatal IV pneumonia.
###end p 8
###begin title 9
RESULTS
###end title 9
###begin title 10
Genetic deletion of CCR2 reduces mortality, morbidity, and alveolar barrier dysfunction during PR/8 infection
###end title 10
###begin p 11
###xml 125 126 125 126 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib4">4</xref>
###xml 128 130 128 130 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib22">22</xref>
###xml 131 133 131 133 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib24">24</xref>
###xml 231 234 231 234 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 422 430 422 430 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig1" ref-type="fig">Fig. 1 A</xref>
###xml 624 627 624 627 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 839 842 839 842 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 1103 1111 1099 1107 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig1" ref-type="fig">Fig. 1 B</xref>
###xml 1134 1137 1130 1133 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 206 210 <span type="species:ncbi:10090">mice</span>
###xml 235 239 <span type="species:ncbi:10090">mice</span>
###xml 298 303 <span type="species:ncbi:10090">mouse</span>
###xml 461 465 <span type="species:ncbi:10090">mice</span>
###xml 532 536 <span type="species:ncbi:10090">mice</span>
###xml 628 632 <span type="species:ncbi:10090">mice</span>
###xml 813 817 <span type="species:ncbi:10090">mice</span>
###xml 843 847 <span type="species:ncbi:10090">mice</span>
###xml 1036 1040 <span type="species:ncbi:10090">mice</span>
###xml 1138 1142 <span type="species:ncbi:10090">mice</span>
###xml 1208 1212 <span type="species:ncbi:10090">mice</span>
Previous reports suggest that the chemokine receptor CCR2 is critically involved in host immune responses to lung infection (4, 22-24). To investigate the influence of CCR2 on the course of IV pneumonia in mice, C57BL/6 WT and CCR2-/- mice were intratracheally inoculated with a lethal dose of the mouse-adapted IV strain PR/8, and survival and body weight were determined during the 21 d post infection (pi). As shown in Fig. 1 A, only 17.3% of CCR2-deficient mice succumbed to PR/8 infection as compared with 78.4% of infected WT mice (P < 0.005 on days 14-21 pi). Likewise, body weight loss was significantly less in CCR2-/- mice on days 8, 9, and 11 pi. To evaluate whether the observed differences in morbidity and mortality during PR/8 infection were associated with increased severity of lung injury in WT mice as compared with CCR2-/- mice, alveolar barrier function was assessed during a time course of 21 d after PR/8 infection in the two treatment groups. Indeed, alveolar leakage was significantly reduced in CCR2-deficient mice on day 7 pi (1.25 +/- 0.39 vs. 0.54 +/- 0.37 arbitrary units; Fig. 1 B), indicating that CCR2-/- mice develop less alveolar barrier damage upon PR/8 infection than WT mice.
###end p 11
###begin p 12
###xml 0 187 0 187 <bold xmlns:xlink="http://www.w3.org/1999/xlink">CCR2 deficiency is associated with increased survival, reduced body weight loss, attenuated alveolar leakage, and slightly reduced viral clearance during the time course of PR/8 infection</bold>
###xml 269 270 263 264 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 284 287 278 281 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 318 319 286 287 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 508 511 476 479 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 661 664 623 626 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 828 830 764 766 <sub xmlns:xlink="http://www.w3.org/1999/xlink">10</sub>
###xml 525 529 <span type="species:ncbi:10090">mice</span>
###xml 695 699 <span type="species:ncbi:10090">mice</span>
###xml 912 916 <span type="species:ncbi:10090">mice</span>
CCR2 deficiency is associated with increased survival, reduced body weight loss, attenuated alveolar leakage, and slightly reduced viral clearance during the time course of PR/8 infection. (A) Body weight and survival of PR/8-infected sex- and age-matched WT (diamond, n = 23) or CCR2-/- (blacksquare, square, filled, n = 23) were determined until days 14 and 21 pi, respectively in four independent experiments. Error bars show SD. (B) Alveolar leakage was analyzed in PR/8-infected WT (filled bars) or CCR2-/- (empty bars) mice. The ratio of BALF and blood FITC fluorescence is expressed in arbitrary units (AU). (C) Lung virus titers of WT (diamond) and CCR2-/- (blacksquare, square, filled) mice in the time course of PR/8 infection. Virus titers were determined from lung homogenate supernatants and values are given as log10 foci-forming units (FFU)/lung. Data in B and C are means +/- SD of three to five mice per group from at least three independent experiments. *, P < 0.05; ***, P < 0.005.
###end p 12
###begin p 13
###xml 239 242 239 242 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 439 442 439 442 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 575 578 575 578 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 640 641 638 639 <sup xmlns:xlink="http://www.w3.org/1999/xlink">3</sup>
###xml 664 665 660 661 <sup xmlns:xlink="http://www.w3.org/1999/xlink">3</sup>
###xml 704 712 700 708 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig1" ref-type="fig">Fig. 1 C</xref>
###xml 867 870 863 866 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 243 247 <span type="species:ncbi:10090">mice</span>
###xml 334 339 <span type="species:ncbi:10090">mouse</span>
###xml 443 447 <span type="species:ncbi:10090">mice</span>
###xml 579 583 <span type="species:ncbi:10090">mice</span>
###xml 774 778 <span type="species:ncbi:10090">mice</span>
###xml 871 875 <span type="species:ncbi:10090">mice</span>
During IV pneumonia, alveolar epithelial injury may be caused by direct cytopathic effects of IV replicating primarily in epithelial cells. Therefore, we evaluated whether the observed differences in lung barrier damage between WT and CCR2-/- mice were linked to different viral replication efficiencies in the lung tissue of the two mouse strains. Analyses of viral replication in lung homogenates from PR/8-infected WT compared with CCR2-/- mice revealed no significant differences in peak viral titers at days 2, 3, and 5 pi and even slightly elevated virus titers in CCR2-/- mice during the later stages of infection (1.05 +/- 1.33 x 103 vs. 6.20 +/- 3.90 x 103 foci-forming units/lung on day 11 pi; Fig. 1 C). These results indicate that enhanced alveolar injury in WT mice during PR/8 pneumonia is not caused by higher viral replication rates than those in CCR2-/- mice and rather suggest that mononuclear phagocytes recruited to inflamed tissues in a CCR2-dependent manner may directly cause alveolar damage during IV pneumonia.
###end p 13
###begin title 14
CCR2 deficiency selectively affects alveolar mononuclear phagocyte recruitment during IV pneumonia
###end title 14
###begin p 15
###xml 117 120 117 120 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 356 364 356 364 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig2" ref-type="fig">Fig. 2 A</xref>
###xml 910 911 908 909 <sup xmlns:xlink="http://www.w3.org/1999/xlink">6</sup>
###xml 933 934 929 930 <sup xmlns:xlink="http://www.w3.org/1999/xlink">6</sup>
###xml 936 944 932 940 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig2" ref-type="fig">Fig. 2 B</xref>
###xml 1102 1110 1098 1106 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig2" ref-type="fig">Fig. 2 C</xref>
###xml 1213 1221 1209 1217 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig2" ref-type="fig">Fig. 2 C</xref>
###xml 121 125 <span type="species:ncbi:10090">mice</span>
###xml 435 439 <span type="species:ncbi:10090">mice</span>
###xml 483 487 <span type="species:ncbi:10090">mice</span>
###xml 665 669 <span type="species:ncbi:10090">mice</span>
###xml 856 860 <span type="species:ncbi:10090">mice</span>
###xml 1051 1055 <span type="species:ncbi:10090">mice</span>
###xml 1207 1211 <span type="species:ncbi:10090">mice</span>
To evaluate whether the amount and composition of alveolar leukocyte infiltration differ in PR/8-infected WT and CCR2-/- mice, total bronchoalveolar lavage (BAL) fluid (BALF) cell counts and cell differentials were determined at various time points pi. No significant differences in total BALF cell counts were detectable between the two treatment groups (Fig. 2 A). Peak alveolar neutrophil accumulation was delayed in CCR2-deficient mice and slightly exceeded values reached in WT mice on days 7 and 8 pi. Lymphocyte recruitment was virtually identical in both treatment groups. Total numbers of resident alveolar macrophages in BALF were lower in CCR2-deficient mice on days 5-9 pi but reached comparable levels during the later stages of infection. However, alveolar mononuclear phagocyte recruitment was found to be strongly reduced in CCR2-deficient mice, most prominently at day 8 pi (1.27 +/- 0.35 x 106 vs. 0.3 +/- 0.21 x 106; Fig. 2 B). Correspondingly, exudate mononuclear phagocyte numbers were significantly decreased in PR/8-infected WT mice pretreated with an anti-CCR2 mAb by day 8 pi (Fig. 2 C, left), which is associated with reduced alveolar leakage, as compared with isotype IgG-treated mice (Fig. 2 C, right), suggesting a key role of alveolar recruited mononuclear phagocytes in IV-induced lung barrier breakdown.
###end p 15
###begin p 16
###xml 0 72 0 72 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Alveolar macrophage recruitment in PR/8-infected mice is CCR2 dependent.</bold>
###xml 121 124 121 124 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 699 702 699 702 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 823 824 823 824 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 910 913 910 913 <sup xmlns:xlink="http://www.w3.org/1999/xlink">int</sup>
###xml 918 919 918 919 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 1038 1041 1038 1041 <sup xmlns:xlink="http://www.w3.org/1999/xlink">int</sup>
###xml 1094 1098 1094 1098 <sup xmlns:xlink="http://www.w3.org/1999/xlink">high</sup>
###xml 1164 1168 1164 1168 <sup xmlns:xlink="http://www.w3.org/1999/xlink">high</sup>
###xml 1173 1177 1173 1177 <sup xmlns:xlink="http://www.w3.org/1999/xlink">high</sup>
###xml 1282 1286 1282 1286 <sup xmlns:xlink="http://www.w3.org/1999/xlink">high</sup>
###xml 1291 1295 1291 1295 <sup xmlns:xlink="http://www.w3.org/1999/xlink">high</sup>
###xml 1395 1398 1395 1398 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 1521 1522 1521 1522 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 1559 1562 1559 1562 <sup xmlns:xlink="http://www.w3.org/1999/xlink">low</sup>
###xml 1567 1568 1567 1568 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 1587 1590 1587 1590 <sup xmlns:xlink="http://www.w3.org/1999/xlink">low</sup>
###xml 1593 1594 1593 1594 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 1617 1620 1617 1620 <sup xmlns:xlink="http://www.w3.org/1999/xlink">low</sup>
###xml 1623 1624 1623 1624 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 1718 1719 1718 1719 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 49 53 <span type="species:ncbi:10090">mice</span>
###xml 138 142 <span type="species:ncbi:10090">mice</span>
###xml 443 447 <span type="species:ncbi:10090">mice</span>
###xml 572 576 <span type="species:ncbi:10090">mice</span>
###xml 703 707 <span type="species:ncbi:10090">mice</span>
###xml 719 723 <span type="species:ncbi:10090">mice</span>
###xml 1412 1416 <span type="species:ncbi:10090">mice</span>
Alveolar macrophage recruitment in PR/8-infected mice is CCR2 dependent. (A and B) PR/8-infected WT (filled bars) or CCR2-/- (empty bars) mice were subjected to BAL, followed by quantification of total leukocyte BALF numbers (A) and BAL leukocyte subpopulations (B) from Pappenheim-stained cytocentrifuge preparations. (C) Quantification of exudate mononuclear phagocytes calculated from differential counts of BAL leukocytes from infected WT mice treated with isotype IgG or anti-CCR2 mAb (day 8 pi, left). Alveolar leakage of isotype- or anti-CCR2-treated PR/8-infected mice (day 7 pi, right). (D) FACS analysis of alveolar mononuclear phagocyte subpopulations in BALF from infected WT versus CCR2-/- mice or from WT mice treated with isotype IgG or anti-CCR2 mAb was performed by three-hierarchy gating on day 8 pi. CD45+ cells (population 1 [P1]) were gated according to their GR1 and F4/80 expression. GR1intF4/80+ cells represent alveolar mononuclear phagocytes (population 2 [P2]). Subgate analysis of population 2 revealed a CD11cint (population 3 [P3], exudate macrophages) and a CD11chigh (population 4 [P4], resident AM) subpopulation as well as a CD11chighMHCIIhigh subpopulation (population 5 [P5]) representing alveolar DCs. (E) Flow cytometric quantification of CD11chighMHCIIhigh DCs and lymphocyte subpopulations from BAL leukocytes of PR/8-infected WT (filled bars) versus CCR2-/- (empty bars) mice using the gating characteristics described in D for DCs. For analysis of lymphocyte subpopulations, CD45+ cells were subgated on NK cells (SSClowNK1.1+), CD4 T cells (SSClowCD4+), and CD8 T cells (SSClowCD8+). Data in E are given as total cells in BAL calculated from the respective percentage of CD45+ cells. All bar graphs represent the means +/- SD from five experiments. *, P < 0.05; ***, P < 0.005. AM, alveolar macrophages; ex, exudate; mn, mononuclear; iso, isotype IgG.
###end p 16
###begin p 17
###xml 239 240 239 240 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 267 275 267 275 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig2" ref-type="fig">Fig. 2 D</xref>
###xml 365 369 365 369 <sup xmlns:xlink="http://www.w3.org/1999/xlink">high</sup>
###xml 374 375 374 375 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</sup>
###xml 392 393 392 393 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</sup>
###xml 398 399 398 399 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</sup>
###xml 420 423 420 423 <sup xmlns:xlink="http://www.w3.org/1999/xlink">int</sup>
###xml 428 429 428 429 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 468 476 468 476 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig2" ref-type="fig">Fig. 2 D</xref>
###xml 524 527 524 527 <sup xmlns:xlink="http://www.w3.org/1999/xlink">int</sup>
###xml 593 597 593 597 <sup xmlns:xlink="http://www.w3.org/1999/xlink">high</sup>
###xml 702 703 702 703 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib2">2</xref>
###xml 705 706 705 706 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib3">3</xref>
###xml 787 790 787 790 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 910 918 910 918 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig2" ref-type="fig">Fig. 2 D</xref>
###xml 1022 1023 1022 1023 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 1028 1032 1028 1032 <sup xmlns:xlink="http://www.w3.org/1999/xlink">high</sup>
###xml 1054 1062 1054 1062 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig2" ref-type="fig">Fig. 2 D</xref>
###xml 1137 1140 1137 1140 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 1214 1222 1214 1222 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig2" ref-type="fig">Fig. 2 E</xref>
###xml 1349 1350 1349 1350 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 1365 1366 1365 1366 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 1508 1511 1508 1511 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 1518 1526 1518 1526 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig2" ref-type="fig">Fig. 2 E</xref>
###xml 1821 1824 1821 1824 <sup xmlns:xlink="http://www.w3.org/1999/xlink">int</sup>
###xml 1829 1830 1829 1830 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 1835 1838 1835 1838 <sup xmlns:xlink="http://www.w3.org/1999/xlink">int</sup>
###xml 1843 1846 1843 1846 <sup xmlns:xlink="http://www.w3.org/1999/xlink">low</sup>
###xml 111 115 <span type="species:ncbi:10090">mice</span>
###xml 791 795 <span type="species:ncbi:10090">mice</span>
###xml 802 806 <span type="species:ncbi:10090">mice</span>
###xml 862 866 <span type="species:ncbi:10090">mice</span>
###xml 890 894 <span type="species:ncbi:10090">mice</span>
###xml 1141 1145 <span type="species:ncbi:10090">mice</span>
###xml 1196 1200 <span type="species:ncbi:10090">mice</span>
###xml 1405 1409 <span type="species:ncbi:10090">mice</span>
###xml 1512 1516 <span type="species:ncbi:10090">mice</span>
###xml 1721 1725 <span type="species:ncbi:10090">mice</span>
###xml 1944 1948 <span type="species:ncbi:10090">mice</span>
To further dissect the alveolar mononuclear phagocyte subset composition, BALF cells gained from PR/8-infected mice of the various treatment groups were subjected to FACS analysis for surface marker expression at day 8 pi. Analysis of CD45+ BALF cells (population 1; Fig. 2 D, first column) for GR1 and F4/80 expression revealed three distinct cell populations: Gr1highF4/80- neutrophils, GR1-F4/80- lymphocytes, and GR1intF4/80+ mononuclear phagocytes (population 2; Fig. 2 D, second column), which were composed of a CD11cint (population 3, henceforth termed exudate macrophages) and a CD11chigh (population 4) subpopulation, representing resident alveolar macrophages according to previous reports (2, 3). Exudate macrophages (population 3) accumulated to a much lesser extent in CCR2-/- mice or in mice pretreated with anti-CCR2 antibody as compared with WT mice or isotype IgG-treated mice, respectively (Fig. 2 D, third column). Alveolar mononuclear phagocytes (population 2) contained a low proportion of DCs (CD11c+MHCIIhigh [population 5 (P5)]; Fig. 2 D, fourth column). Alveolar DC recruitment was delayed in PR/8-infected CCR2-/- mice but reached peak values comparable to those of WT mice by day 8 pi (Fig. 2 E, top left). Flow cytometric analysis of alveolar lymphocyte subsets revealed no striking differences in the recruitment of CD4+ T cells or CD8+ T cells between WT and CCR2-deficient mice at the given time points, whereas alveolar NK cell accumulation peaked earlier at day 5 pi in CCR2-/- mice (Fig. 2 E). Analysis of interstitial exudate macrophage accumulation in PR/8-infected lungs revealed faster recruitment kinetics than in the alveolar compartment but was likewise significantly reduced in mice lacking CCR2 (Fig. S1, available at ). Altogether, our data demonstrate that recruitment of GR1intF4/80+CD11cintMHCIIlow exudate macrophages into the lungs during PR/8 pneumonia was severely impaired in CCR2-deficient mice or WT animals treated with function blocking anti-CCR2 antibodies.
###end p 17
###begin title 18
CCR2 expression on circulating leukocytes, but not on lung resident cells, is associated with alveolar barrier dysfunction during PR/8 infection
###end title 18
###begin p 19
###xml 223 226 223 226 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 444 447 444 447 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 473 476 473 476 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 528 531 528 531 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 566 567 566 567 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 725 728 725 728 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 890 892 890 892 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib25">25</xref>
###xml 1158 1159 1156 1157 <sup xmlns:xlink="http://www.w3.org/1999/xlink">6</sup>
###xml 1229 1230 1225 1226 <sup xmlns:xlink="http://www.w3.org/1999/xlink">6</sup>
###xml 1270 1273 1266 1269 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 1317 1318 1311 1312 <sup xmlns:xlink="http://www.w3.org/1999/xlink">6</sup>
###xml 1370 1385 1364 1379 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig3" ref-type="fig">Fig. 3, A and B</xref>
###xml 1489 1492 1483 1486 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 1552 1560 1546 1554 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig3" ref-type="fig">Fig. 3 C</xref>
###xml 227 231 <span type="species:ncbi:10090">mice</span>
###xml 262 267 <span type="species:ncbi:10090">mouse</span>
###xml 337 341 <span type="species:ncbi:10090">mice</span>
###xml 391 395 <span type="species:ncbi:10090">mice</span>
###xml 490 494 <span type="species:ncbi:10090">mice</span>
###xml 992 996 <span type="species:ncbi:10090">mice</span>
###xml 1093 1097 <span type="species:ncbi:10090">mice</span>
###xml 1161 1165 <span type="species:ncbi:10090">mice</span>
###xml 1236 1240 <span type="species:ncbi:10090">mice</span>
###xml 1455 1459 <span type="species:ncbi:10090">mice</span>
###xml 1510 1514 <span type="species:ncbi:10090">mice</span>
To distinguish whether CCR2 expressed on resident lung cells, such as resident alveolar macrophages or AEC, or CCR2 present on circulating leukocytes accounted for the increased IV-induced alveolar leakage in WT versus CCR2-/- mice, we made use of a BM chimeric mouse model. We established three different transplantation groups: (a) WT mice with transplantation of 100% WT BM cells; (b) WT mice with transplantation of a mixture of WT and CCR2-/- BM cells (50% WT/50% CCR2-/-); and (c) WT mice with transplantation of 100% CCR2-/- BM cells. CCR2 expression on F4/80+ peripheral blood monocytes was analyzed 14 d after transplantation by flow cytometry and corresponded to the respective proportion of transplanted WT or CCR2-/- BM cells in the different transplantation groups, whereas resident alveolar macrophages homogeneously displayed a WT phenotype as previously outlined in detail (25) (unpublished data). Exudate macrophage accumulation on day 8 after PR/8 infection in transplanted mice was dependent on the proportion of peripheral blood monocytes with intact CCR2 expression, with mice after transplantation of WT BM recruiting 0.85 +/- 0.27 x 106, mice after transplantation of mixed BM recruiting 0.57 +/- 0.29 x 106, and mice after transplantation of CCR2-/- BM recruiting a total of 0.24 +/- 0.09 x 106 exudate macrophages into the alveolar compartment (Fig. 3, A and B). Notably, alveolar leakage at day 7 pi was significantly reduced in mice after transplantation of CCR2-/- BM compared with mice after transplantation of 100% WT BM (Fig. 3 C). These results clearly demonstrate that CCR2 expressed on circulating blood monocytes is critically involved in mononuclear phagocyte extravasation into the alveolar compartment of the lung, thereby contributing to alveolar barrier dysfunction during IV pneumonia.
###end p 19
###begin p 20
###xml 0 112 0 112 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Alveolar barrier dysfunction is associated with CCR2 expression on circulating leukocytes during PR/8 infection.</bold>
###xml 299 302 299 302 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 368 371 368 371 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 688 696 688 696 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig2" ref-type="fig">Fig. 2 D</xref>
###xml 169 173 <span type="species:ncbi:10090">mice</span>
###xml 188 192 <span type="species:ncbi:10090">mice</span>
###xml 248 252 <span type="species:ncbi:10090">mice</span>
###xml 330 334 <span type="species:ncbi:10090">mice</span>
###xml 623 627 <span type="species:ncbi:10090">mice</span>
###xml 993 997 <span type="species:ncbi:10090">mice</span>
###xml 1070 1074 <span type="species:ncbi:10090">mice</span>
Alveolar barrier dysfunction is associated with CCR2 expression on circulating leukocytes during PR/8 infection. (A) Three different groups of PR/8-infected BM chimeric mice (WT recipient mice with transplantation of 100% WT BM cells; WT recipient mice with transplantation of mixed 50% WT/ 50% CCR2-/- BM cells; and WT recipient mice with transplantation of 100% CCR2-/- BM cells) were subjected to BAL at day 8 pi. Exudate macrophage numbers were calculated from BALF leukocyte numbers and differential counts of Pappenheim-stained cytocentrifuge preparations. (B) FACS analysis of BALF cells from PR/8-infected chimeric mice of each transplantation group was performed as described in Fig. 2 D, and representative dot plots from three independent experiments are shown. Note that population 3 (P3; exudate macrophages), population 4 (P4; resident alveolar macrophages), and population 5 (P5; alveolar DCs) are subgates of population 2 [P2]. (C) Alveolar leakage from PR/8-infected chimeric mice at day 7 pi. All bar graphs represent the means +/- SD of four to eight mice per group from three independent experiments. ***, P < 0.005.
###end p 20
###begin title 21
CCR2-dependent alveolar exudate macrophage accumulation is associated with increased AEC apoptosis
###end title 21
###begin p 22
###xml 400 408 400 408 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig4" ref-type="fig">Fig. 4 A</xref>
###xml 490 493 490 493 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 770 771 770 771 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</sup>
###xml 891 899 887 895 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig4" ref-type="fig">Fig. 4 B</xref>
###xml 1233 1236 1229 1232 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 1341 1349 1337 1345 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig4" ref-type="fig">Fig. 4 B</xref>
###xml 1404 1405 1400 1401 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 1612 1615 1608 1611 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 1622 1637 1618 1633 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig4" ref-type="fig">Fig. 4, B and C</xref>
###xml 1662 1663 1658 1659 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</sup>
###xml 1667 1668 1663 1664 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 1774 1777 1770 1773 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 352 356 <span type="species:ncbi:10090">mice</span>
###xml 494 498 <span type="species:ncbi:10090">mice</span>
###xml 519 523 <span type="species:ncbi:10090">mice</span>
###xml 569 573 <span type="species:ncbi:10090">mice</span>
###xml 1028 1032 <span type="species:ncbi:10090">mice</span>
###xml 1070 1074 <span type="species:ncbi:10090">mice</span>
###xml 1237 1241 <span type="species:ncbi:10090">mice</span>
###xml 1473 1477 <span type="species:ncbi:10090">mice</span>
###xml 1616 1620 <span type="species:ncbi:10090">mice</span>
###xml 1778 1782 <span type="species:ncbi:10090">mice</span>
Given that the CCR2-dependent accumulation of exudate macrophages in IV pneumonia contributed to the loss of alveolar barrier integrity, we hypothesized that this recruited mononuclear cell population might promote barrier dysfunction by inducing AEC apoptosis. Therefore, cryosections from lavaged lungs of mock- or PR/8-infected WT or CCR2-deficient mice were subjected to TUNEL assay. As shown in Fig. 4 A, the number of apoptotic alveolar cells was strikingly less in PR/8-infected CCR2-/- mice as compared with WT mice, and virtually undetectable in mock-infected mice. For apoptosis quantification of AEC type I representing the major component of the alveolar surface, lung homogenates of the respective treatment groups were subjected to flow cytometry, and CD45- cells were analyzed for annexin V binding and expression of the AEC type I marker T1alpha. Representative dot plots in Fig. 4 B (left) demonstrate a significantly larger proportion of type I AEC to undergo apoptosis in lung homogenates of PR/8-infected WT mice than in PR/8-infected CCR2-deficient mice at day 7 pi. Flow cytometric quantification during the time course of infection revealed a sustained increase of type I AEC apoptosis in WT compared with CCR2-/- mice throughout days 7-11 pi corresponding to the kinetics of alveolar exudate macrophage accumulation (Fig. 4 B, right). The proportions of infected (IV nucleoprotein+) type I AEC were virtually identical in both WT and CCR2-deficient mice, with direct viral cytopathic effects most likely accounting for the observed type I AEC apoptosis rate that was still present in CCR2-/- mice (Fig. 4, B and C). No differences in CD45-CD31+ lung endothelial cell apoptosis could be detected during days 5-14 in PR/8-infected WT compared with CCR2-/- mice (unpublished data).
###end p 22
###begin p 23
###xml 46 49 46 49 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 0 77 0 77 <bold xmlns:xlink="http://www.w3.org/1999/xlink">AEC apoptosis is reduced in PR/8-infected CCR2<sup>&#8722;/&#8722;</sup> mice compared with WT mice.</bold>
###xml 92 95 92 95 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 432 435 431 434 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 642 643 637 638 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</sup>
###xml 813 814 808 809 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 833 834 828 829 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</sup>
###xml 842 843 833 834 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 896 897 887 888 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 916 917 907 908 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</sup>
###xml 925 926 912 913 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 1172 1175 1157 1160 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 50 54 <span type="species:ncbi:10090">mice</span>
###xml 72 76 <span type="species:ncbi:10090">mice</span>
###xml 96 100 <span type="species:ncbi:10090">mice</span>
###xml 436 440 <span type="species:ncbi:10090">mice</span>
###xml 761 765 <span type="species:ncbi:10090">mice</span>
###xml 1037 1041 <span type="species:ncbi:10090">mice</span>
AEC apoptosis is reduced in PR/8-infected CCR2-/- mice compared with WT mice. (A) WT or CCR2-/- mice were mock or PR/8 infected and TUNEL assay was performed on cryosections from lavaged lungs at day 7 pi. Nuclei of apoptotic cells appear in brown. Arrows, apoptotic intraalveolar leukocytes; arrowheads, apoptotic AEC. Bars, 100 mum. (B) Flow cytometric quantification of apoptotic AEC. Lungs from mock- or PR/8-infected WT or CCR2-/- mice were digested on day 7 pi and analyzed for annexin V binding. Representative dot plots show expression of the AEC type I marker T1alpha and annexin V staining of viable (propidium iodide negative) CD45- cells. Apoptotic cells are mainly AEC type I (left). Quantification of FACS data as obtained in B from PR/8-infected mice (right). The bar graph represents the annexin V+ proportion of CD45- T1alpha+ cells. (C) Quantification of FACS analysis of the NP+ proportion of CD45- T1alpha+ cells from lung homogenates in the time course after PR/8 infection. Values are means +/- SD of three to four mice per group from three independent experiments. *, P < 0.05; ***, P < 0.005. NP, IV nucleoprotein; filled bars, WT; empty bars, CCR2-/-.
###end p 23
###begin title 24
Alveolar exudate macrophages up-regulate messenger RNA (mRNA) levels of proapoptotic TRAIL as compared with peripheral blood monocytes
###end title 24
###begin p 25
###xml 354 362 354 362 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig5" ref-type="fig">Fig. 5 A</xref>
###xml 682 690 674 682 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig5" ref-type="fig">Fig. 5 B</xref>
###xml 988 991 972 975 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 1133 1141 1113 1121 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig5" ref-type="fig">Fig. 5 B</xref>
###xml 1329 1337 1309 1317 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig5" ref-type="fig">Fig. 5 B</xref>
###xml 183 187 <span type="species:ncbi:10090">mice</span>
###xml 251 255 <span type="species:ncbi:10090">mice</span>
###xml 619 623 <span type="species:ncbi:10090">mice</span>
###xml 676 680 <span type="species:ncbi:10090">mice</span>
###xml 814 818 <span type="species:ncbi:10090">mice</span>
###xml 992 996 <span type="species:ncbi:10090">mice</span>
###xml 1323 1327 <span type="species:ncbi:10090">mice</span>
To analyze mRNA levels of potential proapoptotic factors in alveolar exudate macrophages and their blood precursors, peripheral blood monocytes from mock-infected or PR/8-infected WT mice, as well as alveolar exudate macrophages from PR/8-infected WT mice, were flow sorted on day 8 pi according to scatter and surface marker characteristics as shown in Fig. 5 A and analyzed for TNF-alpha, TRAIL, and FasL transcripts using quantitative RT-PCR. TNF-alpha mRNA transcripts were found to be significantly increased to the same level in both peripheral blood monocytes and alveolar exudate macrophages from PR/8-infected mice as compared with blood monocytes from mock infected mice (Fig. 5 B, left). However, TNF-alpha protein levels in BALF did not significantly differ between PR/8-infected WT and CCR2-deficient mice on day 7 pi (348 +/- 65 and 266 +/- 113pg/ml, respectively; unpublished data), suggesting that exudate macrophages recruited to the alveolar space in WT but less in CCR2-/- mice were not the primary source of TNF-alpha. No significant up-regulation of FasL mRNA could be detected in the analyzed cell populations (Fig. 5 B, middle). In contrast, TRAIL mRNA was selectively up-regulated fourfold in exudate macrophages as compared with their peripheral blood precursors from either mock- or PR/8-infected mice (Fig. 5 B, right).
###end p 25
###begin p 26
###xml 0 148 0 144 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Relative mRNA expression of the proapoptotic factors TNF-&#945;, TRAIL, and FasL in peripheral blood (PB) monocytes and alveolar exudate macrophages.</bold>
###xml 324 325 320 321 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 328 331 324 327 <sup xmlns:xlink="http://www.w3.org/1999/xlink">int</sup>
###xml 336 339 332 335 <sup xmlns:xlink="http://www.w3.org/1999/xlink">int</sup>
###xml 510 513 506 509 <sup xmlns:xlink="http://www.w3.org/1999/xlink">low</sup>
###xml 552 553 548 549 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 558 559 554 555 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 944 945 934 935 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 209 213 <span type="species:ncbi:10090">mice</span>
###xml 441 445 <span type="species:ncbi:10090">mice</span>
###xml 774 778 <span type="species:ncbi:10090">mice</span>
###xml 819 823 <span type="species:ncbi:10090">mice</span>
###xml 950 954 <span type="species:ncbi:10090">mice</span>
Relative mRNA expression of the proapoptotic factors TNF-alpha, TRAIL, and FasL in peripheral blood (PB) monocytes and alveolar exudate macrophages. (A) BALF exudate alveolar macrophages from PR/8-infected WT mice were high-purity flow sorted on day 8 pi according to their surface expression of F4/80, GR1, and CD11c (F4/80+GR1intCD11cint [population 3 (P3)], left). PB monocytes from the same (PR/8 infected) animals or from mock-infected mice were flow sorted according to their scatter characteristics (SSClow) and CD11b and CD115 expression (CD11b+CD115+ [population 3 (P3)], right). SSC, side scatter; FSC, forward scatter. (B) Relative mRNA expression of TNF-alpha, TRAIL, and FasL from sorted PB monocytes of mock-infected (PB-Mo mock) or PR/8-infected (PB-Mo PR/8) mice or from exudate macrophages of infected mice (ExMa PR/8). Values are the means +/- SD from three independent experiments, including pooled BALF or blood cells, from n = 8 mice each. *, P < 0.05.
###end p 26
###begin title 27
TRAIL expression in the alveolar space is largely restricted to alveolar exudate macrophages during PR/8 infection
###end title 27
###begin p 28
###xml 137 140 137 140 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 260 261 260 261 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 447 455 447 455 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig6" ref-type="fig">Fig. 6 A</xref>
###xml 487 488 487 488 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 527 528 527 528 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 671 679 659 667 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig6" ref-type="fig">Fig. 6 A</xref>
###xml 721 723 709 711 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib18">18</xref>
###xml 823 826 811 814 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 864 865 852 853 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 873 874 861 862 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 939 942 927 930 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 978 986 966 974 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig6" ref-type="fig">Fig. 6 B</xref>
###xml 141 145 <span type="species:ncbi:10090">mice</span>
###xml 318 322 <span type="species:ncbi:10090">mice</span>
###xml 577 581 <span type="species:ncbi:10090">mice</span>
###xml 633 637 <span type="species:ncbi:10090">mice</span>
###xml 943 947 <span type="species:ncbi:10090">mice</span>
To evaluate TRAIL protein expression on the surface of alveolar mononuclear phagocytes, BALF cells from mock- or PR/8-infected WT or CCR2-/- mice were analyzed by flow cytometry for F4/80 and TRAIL coexpression by day 8 pi. TRAIL was exclusively found on F4/80+ BALF cells from PR/8-infected WT but not CCR2-deficient mice, indicating that only CCR2 dependently recruited exudate macrophages but not resident alveolar macrophages expressed TRAIL (Fig. 6 A, left). The proportion of TRAIL+ alveolar mononuclear phagocytes (F4/80+) raised to approximately14% in PR/8-infected WT mice on day 8 pi and was always <1.5% in CCR2-deficient mice in the time course of infection (Fig. 6 A, right). As opposed to previous reports (18), in our model, TRAIL was only expressed on a small proportion of alveolar NK cells (WT, 5.6%; CCR2-/-, 5.2%) and was absent on alveolar CD4+ and CD8+ T cells as well as on alveolar neutrophils from both WT and CCR2-/- mice at the indicated time points (Fig. 6 B). In addition, TRAIL was undetectable on each of these leukocyte populations including monocytes in peripheral blood (unpublished data).
###end p 28
###begin p 29
###xml 0 71 0 71 <bold xmlns:xlink="http://www.w3.org/1999/xlink">TRAIL is expressed on the cell surface of alveolar exudate macrophages.</bold>
###xml 86 89 86 89 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 237 240 237 240 <sup xmlns:xlink="http://www.w3.org/1999/xlink">int</sup>
###xml 245 246 245 246 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 362 363 362 363 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 374 375 374 375 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 437 440 437 440 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 551 554 551 554 <sup xmlns:xlink="http://www.w3.org/1999/xlink">low</sup>
###xml 559 560 559 560 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 579 583 579 583 <sup xmlns:xlink="http://www.w3.org/1999/xlink">high</sup>
###xml 588 589 588 589 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 608 611 608 611 <sup xmlns:xlink="http://www.w3.org/1999/xlink">low</sup>
###xml 614 615 614 615 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 638 641 638 641 <sup xmlns:xlink="http://www.w3.org/1999/xlink">low</sup>
###xml 644 645 644 645 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 680 683 680 683 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 90 94 <span type="species:ncbi:10090">mice</span>
###xml 441 445 <span type="species:ncbi:10090">mice</span>
###xml 693 697 <span type="species:ncbi:10090">mice</span>
###xml 778 782 <span type="species:ncbi:10090">mice</span>
TRAIL is expressed on the cell surface of alveolar exudate macrophages. (A) WT or CCR2-/- mice were mock or PR/8 infected and BAL cells were stained with GR1-FITC, F4/80-Alexa Fluor 647, and TRAIL PE or isotype PE mAbs, respectively. GR1intF4/80+ cells were gated and analyzed for TRAIL surface expression (left). Quantitative analysis of the proportion of TRAIL+ from F4/80+ BALF cells gained from PR/8-infected WT (filled bars) or CCR2-/- mice (empty bars) on days 5, 8, and 11 pi (right). (B) FACS analysis of TRAIL expression on BALF NK cells (SSClowNK1.1+), neutrophils (GR1highF4/80+), CD8 T cells (SSClowCD8+), and CD4 T cells (SSClowCD4+) of PR/8-infected WT (top) or CCR2-/- (bottom) mice gained at the indicated time points. Values are the means +/- SD of two to four mice per group from at least two independent experiments. ***, P < 0.005.
###end p 29
###begin title 30
###xml 65 69 <span type="species:ncbi:10090">mice</span>
Absence of TRAIL on alveolar exudate macrophages in x31-infected mice is associated with preservation of alveolar barrier function
###end title 30
###begin p 31
###xml 471 474 471 474 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 481 489 481 489 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig7" ref-type="fig">Fig. 7 A</xref>
###xml 641 649 641 649 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig7" ref-type="fig">Fig. 7 B</xref>
###xml 795 803 783 791 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig7" ref-type="fig">Fig. 7 C</xref>
###xml 884 885 872 873 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 943 951 931 939 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig7" ref-type="fig">Fig. 7 D</xref>
###xml 38 42 <span type="species:ncbi:10090">mice</span>
###xml 217 221 <span type="species:ncbi:10090">mice</span>
###xml 367 371 <span type="species:ncbi:10090">mice</span>
###xml 475 479 <span type="species:ncbi:10090">mice</span>
###xml 635 639 <span type="species:ncbi:10090">mice</span>
###xml 780 785 <span type="species:ncbi:10090">mouse</span>
###xml 937 941 <span type="species:ncbi:10090">mice</span>
Given that PR/8 is highly virulent in mice, we questioned whether exudate macrophages would also act pro-apoptotically toward AECs upon a less severe viral lung infection. Therefore, we infected WT and CCR2-deficient mice with a less pathogenic IV strain, x31, at a nonlethal dose. Upon x31 infection, exudate macrophages accumulated in the alveolar air spaces of WT mice (yet to a lower extent than upon PR/8 infection) and were significantly reduced in the BALF of CCR2-/- mice (Fig. 7 A). However, in contrast to PR/8 infection, x31 induced only a mild alveolar leakage on day 7 pi without differences between WT and CCR2-deficient mice (Fig. 7 B). Accordingly, AEC type I apoptosis was present on day 7 pi (approximately25%) but no differences were detectable between the two mouse strains (Fig. 7 C). Interestingly, this was correlated to the absence of TRAIL expression on F4/80+ alveolar mononuclear phagocytes in x31-infected WT mice (Fig. 7 D), indicating that the induction of TRAIL on exudate macrophages is linked to more severe alveolar inflammation as observed in PR/8 infection.
###end p 31
###begin p 32
###xml 24 27 24 27 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 0 149 0 149 <bold xmlns:xlink="http://www.w3.org/1999/xlink">x31-infected WT and CCR2<sup>&#8722;/&#8722;</sup> mice lack TRAIL expression on exudate macrophages and reveal equal levels of AEC apoptosis and alveolar barrier function.</bold>
###xml 299 302 299 302 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 413 416 413 416 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 522 525 522 525 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 612 613 612 613 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 632 633 632 633 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</sup>
###xml 641 642 637 638 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 657 660 653 656 <sup xmlns:xlink="http://www.w3.org/1999/xlink">int</sup>
###xml 665 666 661 662 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 705 708 701 704 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 28 32 <span type="species:ncbi:10090">mice</span>
###xml 316 320 <span type="species:ncbi:10090">mice</span>
###xml 430 434 <span type="species:ncbi:10090">mice</span>
###xml 526 530 <span type="species:ncbi:10090">mice</span>
###xml 709 713 <span type="species:ncbi:10090">mice</span>
x31-infected WT and CCR2-/- mice lack TRAIL expression on exudate macrophages and reveal equal levels of AEC apoptosis and alveolar barrier function. (A) Quantification of BAL exudate mononuclear phagocytes from Pappenheim-stained cytocentrifuge preparations in x31-infected WT (filled bars) or CCR2-/- (empty bars) mice. (B) Alveolar leakage of uninfected (day 0) or x31-infected (day 7) WT (filled bars) or CCR2-/- (empty bars) mice. (C, right) FACS analysis of apoptotic AEC type I from mock- or x31-infected WT or CCR2-/- mice on day 7 pi. (C, left) Quantification of FACS data. Bar graphs show the annexin V+ proportion of CD45- T1alpha+ cells. (D) GR1intF4/80+ BAL cells from x31-infected WT or CCR2-/- mice were gated and analyzed for TRAIL surface expression. *, P < 0.05; ***, P < 0.005. All bar graphs represent the means +/- SD from three independent experiments.
###end p 32
###begin title 33
Anti-TRAIL treatment attenuates alveolar epithelial apoptosis, as well as lung leakage, and enhances survival after PR/8 infection
###end title 33
###begin p 34
###xml 379 380 377 378 <sup xmlns:xlink="http://www.w3.org/1999/xlink">6</sup>
###xml 412 413 408 409 <sup xmlns:xlink="http://www.w3.org/1999/xlink">6</sup>
###xml 428 436 424 432 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig8" ref-type="fig">Fig. 8 A</xref>
###xml 760 768 756 764 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig8" ref-type="fig">Fig. 8 B</xref>
###xml 968 976 964 972 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig8" ref-type="fig">Fig. 8 C</xref>
###xml 1148 1156 1144 1152 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig8" ref-type="fig">Fig. 8 D</xref>
###xml 172 176 <span type="species:ncbi:10090">mice</span>
###xml 287 291 <span type="species:ncbi:10090">mice</span>
###xml 330 334 <span type="species:ncbi:10090">mice</span>
###xml 500 504 <span type="species:ncbi:10090">mice</span>
###xml 555 559 <span type="species:ncbi:10090">mice</span>
###xml 848 852 <span type="species:ncbi:10090">mice</span>
###xml 950 954 <span type="species:ncbi:10090">mice</span>
###xml 1031 1035 <span type="species:ncbi:10090">mice</span>
###xml 1291 1295 <span type="species:ncbi:10090">mice</span>
###xml 1577 1581 <span type="species:ncbi:10090">mice</span>
To evaluate the contribution of exudate macrophage TRAIL to alveolar epithelial apoptosis, TUNEL assay was performed on cryosections of lavaged lungs from PR/8-infected WT mice treated with isotype IgG or anti-TRAIL mAb. Alveolar exudate macrophage numbers in anti-TRAIL- or IgG-treated mice were comparable to those of untreated mice upon PR/8 infection (IgG, 1.97 +/- 0.25 x 106; anti-TRAIL, 1.83 +/- 0.77 x 106). As shown in Fig. 8 A, alveolar cell apoptosis was pronounced in isotype IgG-treated mice but significantly decreased in anti-TRAIL-treated mice on day 7 after PR/8 infection. In addition, anti-TRAIL treatment significantly reduced annexin V binding of AEC type I in PR/8-infected lung homogenates as compared with isotype IgG-treated controls (Fig. 8 B). Analysis of alveolar barrier function in anti-TRAIL-treated PR/8-infected WT mice revealed a significant decrease in alveolar leakage in comparison to isotype IgG-treated control mice on day 7 pi (Fig. 8 C). Reduction of alveolar leakage in anti-TRAIL-treated mice was associated with significantly increased survival of IV infection as compared with isotype-treated controls (Fig. 8 D), although viral clearance from PR/8-infected lungs was substantially delayed upon anti-TRAIL treatment in comparison to untreated WT mice (Fig. S2, available at ). These data clearly demonstrate a crucial role of TRAIL expressed by alveolar exudate macrophages, as opposed to direct viral cytopathic effects, in the development of alveolar barrier dysfunction as a major determinant of mortality during IV pneumonia in mice.
###end p 34
###begin p 35
###xml 0 116 0 116 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Anti-TRAIL treatment attenuates AEC apoptosis as well as alveolar leakage and enhances survival upon PR/8 infection.</bold>
###xml 796 797 782 783 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 826 827 812 813 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 1232 1233 1218 1219 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</sup>
###xml 1241 1242 1223 1224 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 1428 1429 1410 1411 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</sup>
###xml 1437 1438 1415 1416 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 138 142 <span type="species:ncbi:10090">mice</span>
###xml 445 449 <span type="species:ncbi:10090">mice</span>
###xml 548 552 <span type="species:ncbi:10090">mice</span>
###xml 626 630 <span type="species:ncbi:10090">mice</span>
###xml 749 753 <span type="species:ncbi:10090">mice</span>
###xml 1322 1326 <span type="species:ncbi:10090">mice</span>
###xml 1514 1518 <span type="species:ncbi:10090">mice</span>
Anti-TRAIL treatment attenuates AEC apoptosis as well as alveolar leakage and enhances survival upon PR/8 infection. (A) PR/8-infected WT mice were treated with IgG isotype or anti-TRAIL mAb on days 3 and 5 pi and TUNEL assay was performed on lung cryosections at day 7 pi (arrows, apoptotic intraalveolar leukocytes; arrowheads, apoptotic AECs). Bars, 100 mum. (B) FACS analysis (representative dot plots, left) and quantification (four to six mice per group; right) of apoptotic AEC I of PR/8-infected, IgG isotype-treated, or anti-TRAIL-treated mice (day 7 pi). Error bars show SD. (C) Alveolar leakage of PR/8-infected WT mice at day 7 pi that were treated with IgG isotype or anti-TRAIL mAb at days 3 and 5 pi. (D) Survival of PR/8-infected WT mice treated with isotype IgG (black triangle, n = 10) or anti-TRAIL mAb (*, n = 12) at days 3, 5, 7, and 9 pi in three independent experiments. (E) TRAIL receptor DR5 is expressed on cultured AEC and up-regulated upon PR/8 infection dose dependently in vitro. Bar graphs depict DR5 mRNA expression as fold induction of mock-infected AEC. (F) DR5 is expressed on AEC and up-regulated upon PR/8 infection in vivo. Left, FACS analysis of DR5 and NP expression of gated AEC type I (CD45- T1alpha+) from digested lungs of uninfected (day 0, top) or PR/8-infected (day 5 pi) WT mice. Right, histograms depict DR5 expression of NP-negative (medium gray histograms) and NP-positive CD45- T1alpha+ AEC I (dark gray histograms) from noninfected (day 0) and PR/8-infected WT mice in the time course of infection. Isotype PE-stained cells are shown in light gray histograms. An NP-positive population is missing at days 0 and 14 pi. Bar graphs in C and E represent the means +/- SD of three to five independent experiments. *, P < 0.05; ***, P < 0.005; iso, isotype IgG; NP, IV nucleoprotein.
###end p 35
###begin p 36
###xml 188 196 188 196 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig8" ref-type="fig">Fig. 8 E</xref>
###xml 283 284 283 284 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 318 326 318 326 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig8" ref-type="fig">Fig. 8 F</xref>
###xml 375 376 375 376 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 393 394 393 394 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</sup>
###xml 448 456 448 456 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig8" ref-type="fig">Fig. 8 F</xref>
###xml 98 104 <span type="species:ncbi:10090">murine</span>
Interestingly, TRAIL receptor (DR5) mRNA transcripts were found to be present in cultured primary murine AEC and were up-regulated upon PR/8 infection in a dose-dependent manner in vitro (Fig. 8 E). Moreover, DR5 was present on type I AEC and further up-regulated on the infected (NP+) proportion on day 5 pi in vivo (Fig. 8 F, left). Increased DR5 expression persisted on NP+ compared with NP- type I AEC until NP detection was lost by day 14 pi (Fig. 8 F, right), suggesting an enhancing effect of viral infection for macrophage TRAIL-mediated alveolar injury.
###end p 36
###begin title 37
###xml 58 62 <span type="species:ncbi:10090">mice</span>
AEC apoptosis and leakage are attenuated in PR/8-infected mice recruiting TRAIL-deficient exudate macrophages to the alveolar air space
###end title 37
###begin p 38
###xml 348 351 348 351 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 369 372 369 372 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 518 526 518 526 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig9" ref-type="fig">Fig. 9 A</xref>
###xml 584 592 584 592 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig9" ref-type="fig">Fig. 9 B</xref>
###xml 646 649 646 649 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/+</sup>
###xml 927 930 927 930 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/+</sup>
###xml 978 981 978 981 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 1198 1201 1198 1201 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 1251 1254 1251 1254 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/+</sup>
###xml 1259 1262 1259 1262 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/+</sup>
###xml 1269 1272 1269 1272 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 1277 1280 1277 1280 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/+</sup>
###xml 1290 1293 1290 1293 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/+</sup>
###xml 1298 1301 1298 1301 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 1465 1468 1465 1468 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/+</sup>
###xml 1509 1517 1509 1517 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig9" ref-type="fig">Fig. 9 C</xref>
###xml 1641 1644 1641 1644 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/+</sup>
###xml 1761 1764 1761 1764 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/+</sup>
###xml 1769 1772 1769 1772 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/+</sup>
###xml 1796 1797 1794 1795 <sup xmlns:xlink="http://www.w3.org/1999/xlink">5</sup>
###xml 1804 1807 1802 1805 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 1812 1815 1810 1813 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/+</sup>
###xml 1839 1840 1835 1836 <sup xmlns:xlink="http://www.w3.org/1999/xlink">5</sup>
###xml 1884 1887 1880 1883 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 1925 1926 1919 1920 <sup xmlns:xlink="http://www.w3.org/1999/xlink">5</sup>
###xml 2117 2120 2111 2114 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/+</sup>
###xml 2134 2137 2128 2131 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 150 154 <span type="species:ncbi:10090">mice</span>
###xml 271 275 <span type="species:ncbi:10090">mice</span>
###xml 314 318 <span type="species:ncbi:10090">mice</span>
###xml 373 377 <span type="species:ncbi:10090">mice</span>
###xml 417 421 <span type="species:ncbi:10090">mice</span>
###xml 608 612 <span type="species:ncbi:10090">mice</span>
###xml 659 663 <span type="species:ncbi:10090">mice</span>
###xml 888 892 <span type="species:ncbi:10090">mice</span>
###xml 943 947 <span type="species:ncbi:10090">mice</span>
###xml 1212 1216 <span type="species:ncbi:10090">mice</span>
###xml 1412 1416 <span type="species:ncbi:10090">mice</span>
###xml 1574 1578 <span type="species:ncbi:10090">mice</span>
###xml 1620 1624 <span type="species:ncbi:10090">mice</span>
###xml 1853 1857 <span type="species:ncbi:10090">mice</span>
To strengthen the hypothesis that alveolar exudate macrophage accumulation mediates TRAIL-induced injury in PR/8 pneumonia, the following BM chimeric mice were PR/8 infected 2 wk after transplantation and analyzed for epithelial apoptosis and barrier dysfunction: (a) WT mice with transplantation of WT BM; (b) WT mice with transplantation of TRAIL-/- BM; and (c) TRAIL-/- mice with transplantation of WT BM. Indeed, mice that were transplanted with TRAIL-deficient BM displayed reduced alveolar AEC type I apoptosis (Fig. 9 A) and significantly reduced alveolar leakage on day 7 pi (Fig. 9 B) compared with mice that were transplanted with TRAIL+/+ BM, with mice of all transplantation groups recruiting comparable alveolar exudate macrophage numbers (not depicted). Inhibition of alveolar exudate macrophage recruitment by anti-CCR2 antibodies significantly reduced alveolar leakage in mice after transplantation of WT (TRAIL+/+) but not in mice after transplantation of TRAIL-/- BM. These data indicate that TRAIL expression on grafted and then CCR2 dependently recruited cells rather than on lung resident cells is linked to lung injury. In addition, in an adoptive transfer approach using CCR2-/- recipient mice that were either transferred TRAIL+/+/CCR2+/+, TRAIL-/-/CCR2+/+, or TRAIL+/+/CCR2-/- mononuclear cells, alveolar leakage was assessed upon PR/8 infection. In this model, CCR2-deficient recipient mice will largely recruit adoptively transferred CCR2+/+ monocytes into their lungs. As shown in Fig. 9 C, alveolar leakage at day 7 pi was significantly less in mice recruiting TRAIL-deficient compared with mice recruiting TRAIL+/+ exudate macrophages, with comparable alveolar exudate macrophage numbers in both treatment groups at day 7 pi (TRAIL+/+/CCR2+/+ MNC, 5.79 +/- 1.02 x 105; TRAIL-/-/CCR2+/+ MNC, 4.87 +/- 1.48 x 105). Recipient mice that were transferred CCR2-/- MNC recruited only 1.62 +/- 0.99 x 105 exudate macrophages and correspondingly demonstrated low leakage. These data clearly demonstrate that TRAIL-induced lung injury in PR/8 pneumonia is mediated by alveolar recruitment of TRAIL+/+ but not TRAIL-/- exudate macrophages.
###end p 38
###begin p 39
###xml 0 127 0 127 <bold xmlns:xlink="http://www.w3.org/1999/xlink">AEC apoptosis and lung leakage are reduced in PR/8-infected mice recruiting TRAIL-deficient exudate macrophages to their lungs.</bold>
###xml 310 313 310 313 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 333 336 333 336 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 723 726 723 726 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 769 772 769 772 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/+</sup>
###xml 778 781 778 781 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/+</sup>
###xml 787 790 787 790 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/+</sup>
###xml 796 799 796 799 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 808 811 808 811 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 817 820 817 820 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/+</sup>
###xml 60 64 <span type="species:ncbi:10090">mice</span>
###xml 202 206 <span type="species:ncbi:10090">mice</span>
###xml 221 225 <span type="species:ncbi:10090">mice</span>
###xml 276 280 <span type="species:ncbi:10090">mice</span>
###xml 347 351 <span type="species:ncbi:10090">mice</span>
###xml 591 595 <span type="species:ncbi:10090">mice</span>
###xml 727 731 <span type="species:ncbi:10090">mice</span>
###xml 1053 1057 <span type="species:ncbi:10090">mice</span>
AEC apoptosis and lung leakage are reduced in PR/8-infected mice recruiting TRAIL-deficient exudate macrophages to their lungs. (A) Digested lungs of three different groups of PR/8-infected BM chimeric mice (WT recipient mice with transplantation of WT BM cells; WT recipient mice with transplantation of TRAIL-/- BM cells; and TRAIL-/- recipient mice with transplantation of WT BM cells) were analyzed for AEC type I apoptosis (left, representative FACS plots; right, quantitative analysis of five independent experiments). Error bars show SD. (B) Alveolar leakage of different BM chimeric mice that were either left untreated or injected with isotype IgG or anti-CCR2 mAb, respectively, was analyzed at day 7 pi. (C) CCR2-/- mice were adoptively transferred with CCR2+/+/TRAIL+/+, CCR2+/+/TRAIL-/-, or CCR2-/-/TRAIL+/+ MNC, and alveolar leakage was analyzed at day 7 after PR/8 infection. BMT, BM transplantation; iso, isotype IgG; MNC, mononuclear cells; ***, P < 0.005; *, P < 0.05. Bar graphs in B and C represent the means +/- SD of three to five mice per group from three independent experiments.
###end p 39
###begin title 40
DISCUSSION
###end title 40
###begin p 41
###xml 268 270 268 270 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib12">12</xref>
###xml 272 274 272 274 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib26">26</xref>
###xml 276 278 276 278 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib27">27</xref>
###xml 407 409 407 409 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib28">28</xref>
###xml 410 412 410 412 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib30">30</xref>
IV pneumonia is characterized by the rapid development of acute lung injury with a poor outcome. One of the hallmarks of acute lung injury is an incremental alveolar barrier dysfunction followed by accumulation of protein-rich edema fluid in the alveolar compartment (12, 26, 27). Both viral pathogenicity factors and imbalanced host immune responses have been attributed a role in IV-induced lung failure (28-30). However, the molecular cross talk between immune and lung structural cell populations that leads to severe immunopathology and organ dysfunction is largely unknown.
###end p 41
###begin p 42
###xml 271 275 <span type="species:ncbi:10090">mice</span>
###xml 334 338 <span type="species:ncbi:10090">mice</span>
###xml 561 565 <span type="species:ncbi:10090">mice</span>
###xml 743 747 <span type="species:ncbi:10090">mice</span>
###xml 781 785 <span type="species:ncbi:10090">mice</span>
###xml 1017 1021 <span type="species:ncbi:10090">mice</span>
Therefore, we tested the hypothesis that exudate macrophages, recruited to the lung in a CCL2/CCR2-dependent manner, might contribute to lung barrier dysfunction during lethal IV infection. In fact, alveolar barrier function, which is severely affected in IV-infected WT mice, was found to be significantly improved in CCR2-deficient mice exhibiting defective exudate macrophage recruitment. Consequently, CCR2 deficiency was associated with drastically decreased mortality during experimental IV pneumonia. Moreover, the pronounced lung leakage observed in WT mice correlated with an increased AEC apoptosis rate found to be induced by TRAIL, which is predominantly expressed in exudate lung macrophages. Finally, treatment of IV-infected WT mice with an anti-TRAIL mAb or use of mice recruiting TRAIL-deficient exudate macrophages not only attenuated alveolar leakage but significantly reduced mortality from IV pneumonia. Collectively, these results demonstrate that macrophage recruitment to IV-infected lungs in mice exerts detrimental effects on lung parenchymal cells of the highly sensitive gas exchange compartment severely affecting alveolar barrier function via TRAIL-induced epithelial apoptosis.
###end p 42
###begin p 43
###xml 153 154 153 154 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 244 245 244 245 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib1">1</xref>
###xml 247 249 247 249 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib23">23</xref>
###xml 251 253 251 253 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib24">24</xref>
###xml 255 257 255 257 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib31">31</xref>
###xml 258 260 258 260 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib33">33</xref>
###xml 423 424 423 424 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib4">4</xref>
###xml 515 519 <span type="species:ncbi:10090">mice</span>
###xml 656 660 <span type="species:ncbi:10090">mice</span>
CCR2 is known to play a crucial role in host defense against pathogens. Interacting with its primary ligand CCL2 (MCP-1), CCR2 mediates the egress of GR1+ monocytes from the BM and their recruitment from peripheral blood to sites of infection (1, 23, 24, 31-33). In our own previous studies, we demonstrated that monocyte transmigration upon epithelial PR/8 infection in vitro was strictly dependent on the CCL2-CCR2 axis (4). Thus, we assumed that the reduced lung leakage and mortality observed in CCR2-deficient mice during IV infection might be attributed to abrogated pulmonary macrophage accumulation. In fact, as demonstrated by the use of chimeric mice, loss of alveolar barrier function was solely dependent on CCR2 expression on circulating monocytes, indicating that mononuclear phagocyte traffic was critically involved and that CCR2-positive resident lung cell populations did not contribute to increased lung permeability in our model. Interestingly, a reduction of lung macrophage recruitment by 50% resulted in an approximately fivefold decrease in alveolar leakage, suggesting that alveolar damage only occurs beyond a critical threshold of macrophage accumulation and that partial inhibition of macrophage recruitment during IV pneumonia may strongly attenuate lung injury while presumably maintaining critical macrophage host defense functions.
###end p 43
###begin p 44
###xml 48 49 48 49 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 165 168 165 168 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 230 232 230 232 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib32">32</xref>
###xml 234 236 234 236 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib33">33</xref>
###xml 255 256 255 256 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 686 687 674 675 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 742 744 730 732 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib34">34</xref>
###xml 169 173 <span type="species:ncbi:10090">mice</span>
###xml 358 362 <span type="species:ncbi:10090">mice</span>
###xml 392 396 <span type="species:ncbi:10090">mice</span>
###xml 736 740 <span type="species:ncbi:10090">mice</span>
Several authors demonstrated both release of GR1+ monocytes from the BM into the circulation and their inflammatory organ recruitment to be CCR2 dependent, with CCR2-/- mice exhibiting diminished peripheral blood monocyte counts (32, 33). Accordingly, GR1+ peripheral blood monocytes were revealed to be approximately50% less in PR/8-infected CCR2-deficient mice and in anti-CCR2 mAb-treated mice in our study (unpublished data), confirming the aforementioned data and supporting the concept of CCR2 involvement in distinct steps of monocyte homeostasis under inflammatory and noninflammatory conditions. Additionally, direct antibody-mediated cytotoxicity might account for reduced GR1+ blood monocyte numbers in anti-CCR2 mAb-treated mice (34). Therefore, a contribution of reduced circulating monocyte numbers to the attenuation of acute lung injury in IV pneumonia cannot be totally excluded.
###end p 44
###begin p 45
###xml 161 162 161 162 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib1">1</xref>
###xml 334 335 334 335 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 342 343 342 343 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 478 481 478 481 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 482 486 <span type="species:ncbi:10090">mice</span>
###xml 653 657 <span type="species:ncbi:10090">mice</span>
###xml 988 992 <span type="species:ncbi:10090">mice</span>
###xml 1147 1151 <span type="species:ncbi:10090">mice</span>
CCR2 deficiency was found to be associated with a slight but significant delay in viral clearance, confirming observations reported previously by Dawson et al. (1) who suggest delayed adaptive immune responses as the underlying mechanism. However, we were not able to detect significant differences in the alveolar accumulation of CD4+ or CD8+ T lymphocytes despite the observed delay in DC recruitment, which is known as the major APC population. Ongoing IV replication in CCR2-/- mice seemingly had no effect on alveolar epithelial integrity. In fact, epithelial apoptosis occurred when exudate macrophages were alveolar recruited in PR/8-infected WT mice between days 7 and 14 pi. This correlated with the bulk of mortality that was observed when virus titers were already reduced approximately100-fold and IV nucleoprotein detection in AECs declined. These data support the concept that macrophage-mediated immune pathology accounts for the severity of PR/8-induced lung injury in WT mice. Correspondingly, in a milder nonlethal model of IV infection (x31) where exudate macrophage numbers were approximately75% lower than in PR/8-infected WT mice, lung injury was considerably less pronounced, emphasizing the predominant role of host immune responses in IV-induced pathology.
###end p 45
###begin p 46
###xml 177 179 177 179 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib13">13</xref>
###xml 180 182 180 182 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib15">15</xref>
###xml 620 622 620 622 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib35">35</xref>
###xml 624 626 624 626 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib36">36</xref>
###xml 1068 1071 1068 1071 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 1712 1714 1712 1714 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib21">21</xref>
###xml 1716 1718 1716 1718 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib37">37</xref>
###xml 2012 2014 2006 2008 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib20">20</xref>
###xml 2016 2018 2010 2012 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib21">21</xref>
###xml 2186 2188 2180 2182 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib17">17</xref>
###xml 2190 2192 2184 2186 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib18">18</xref>
###xml 2194 2196 2188 2190 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib38">38</xref>
###xml 2295 2297 2289 2291 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib39">39</xref>
###xml 3093 3094 3087 3088 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 3151 3154 3145 3148 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 401 409 <span type="species:ncbi:9606">patients</span>
###xml 973 977 <span type="species:ncbi:10090">mice</span>
###xml 1072 1076 <span type="species:ncbi:10090">mice</span>
###xml 1427 1431 <span type="species:ncbi:10090">mice</span>
###xml 1577 1582 <span type="species:ncbi:9606">human</span>
###xml 1798 1802 <span type="species:ncbi:10090">mice</span>
###xml 2396 2400 <span type="species:ncbi:10090">mice</span>
###xml 2531 2537 <span type="species:ncbi:10090">murine</span>
###xml 2794 2798 <span type="species:ncbi:10090">mice</span>
###xml 3155 3159 <span type="species:ncbi:10090">mice</span>
Alveolar epithelial apoptosis has been described as a common feature of acute lung injury caused by direct or indirect factors such as pneumonia, aspiration, sepsis, or trauma (13-15). Apoptosis is a regulated form of cell death that is mediated by membrane death receptors (extrinsic pathway) and direct mitochondrial injury (intrinsic pathway). Apoptosis has been described to occur in the lungs of patients with acute lung injury by activation of the epithelial membrane Fas death receptor by soluble FasL, released from invading leukocytes and accumulating in a biologically active form at the onset of lung injury (35, 36). However, in our model of IV-induced acute lung injury, FasL transcripts were not differentially regulated in the macrophage subsets analyzed. In contrast, the proapoptotic molecule TRAIL not expressed in peripheral blood monocytes was found to be strongly up-regulated in exudate macrophages recruited into the alveolar space in IV-infected WT mice, whereas TRAIL was undetectable in the alveolar mononuclear phagocytes of IV-infected CCR2-/- mice. TRAIL induction in alveolar exudate macrophages may be caused by the recruitment process into the lung itself or by inflammatory mediators present within the IV-infected alveolar compartment. Notably, TRAIL induction on recruited macrophages was observed in PR/8 infection, representing a very severe and highly inflammatory form of IV pneumonia in mice, but not in x31 infection, suggesting that TRAIL-mediated alveolar injury might be restricted to severe forms of IV pneumonia as observed during human H5N1 infections. Consistent with this, previous reports identified type I IFNs as potent inducers of TRAIL in monocytes and DCs (21, 37). Indeed, we found IFN-alpha to be alveolar released upon PR/8 infection in WT mice yet peaking early by day 2 pi (219 +/- 78 pg/ml; unpublished data). TRAIL, acting as a membrane-bound or soluble form, has been known to induce apoptosis in various tumor cells but not in nonneoplastic cells (20, 21). Recently, TRAIL expressed on lymphocyte subpopulations, DCs, and monocyte-derived macrophages has been associated with antiviral host responses during IV infection (17, 18, 38), underlining the importance of death pathways in antiviral immunity. In contrast, Wurzer et al. (39) found TRAIL-induced programmed cell death pathways to be crucial for IV propagation in vitro. In mice, TRAIL exclusively acts via the membrane DR5 that is expressed on the target cell. Interestingly, DR5 was up-regulated in primary murine AECs in vitro and in vivo upon PR/8 infection, suggesting that a preceding epithelial IV infection might facilitate TRAIL-induced apoptosis as a potential host mechanism to limit viral spread. Indeed, in our model, PR/8 clearance revealed to be delayed in mice upon anti-TRAIL treatment. However, DR5 expression was also detectable in uninfected epithelial cells, indicating that exudate macrophage TRAIL may have the potential to attack noninfected epithelial cells as well when released in large amounts. Consistent with this, the number of infected (NP+) AECs was only slightly reduced in WT compared with CCR2-/- mice on days 11 and 14 pi, indicating only partial selectivity of TRAIL-mediated killing between infected and noninfected cells. These data suggest that, upon such conditions, the destructive effects of TRAIL prevail over its antiviral function thereby leading to enhanced lung injury and mortality.
###end p 46
###begin p 47
###xml 16 18 16 18 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib40">40</xref>
###xml 517 519 505 507 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib41">41</xref>
###xml 713 715 701 703 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib40">40</xref>
###xml 450 454 <span type="species:ncbi:10090">mice</span>
###xml 615 619 <span type="species:ncbi:10090">mice</span>
A recent study (40) confirms the concept that monocyte-derived cells significantly contribute to immunopathology and lung injury in PR/8 pneumonia, but the authors suggest the underlying mechanism to be an increased production of inducible nitric oxide synthase and TNF-alpha. Regarding TNF-alpha release, we could not detect significant differences in alveolar-secreted TNF-alpha during the time course after PR/8 infection in WT and CCR2-deficient mice (unpublished data). As previously published by Akaike et al. (41), reactive oxygen and nitrogen species have been detected in the alveolar fluid of IV infected mice, and macrophages and neutrophils were identified as the primary source. Although Lin et al. (40) did not provide direct evidence that monocyte/macrophage-derived reactive nitrogen species accounted for the observed lung damage in their model, it is conceivable that macrophage-released proinflammatory mediators additionally contribute to lung injury in IV pneumonia.
###end p 47
###begin p 48
###xml 231 235 <span type="species:ncbi:10090">mice</span>
###xml 371 379 <span type="species:ncbi:9606">patients</span>
Altogether, our study demonstrates for the first time a key role of exudate macrophage TRAIL in AEC apoptosis promoting alveolar barrier dysfunction during IV lung infection. Notably, inhibition of TRAIL activity largely protected mice from lethal IV pneumonia. Targeting the TRAIL-DR5 pathway might therefore be a suitable tool for restoring lung epithelial function in patients suffering from severe IV pneumonia.
###end p 48
###begin title 49
MATERIALS AND METHODS
###end title 49
###begin title 50
Reagents.
###end title 50
###begin p 51
###xml 359 360 355 356 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 987 990 973 976 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 1161 1164 1145 1148 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 1202 1204 1186 1188 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib42">42</xref>
###xml 19 24 <span type="species:ncbi:10090">mouse</span>
###xml 366 371 <span type="species:ncbi:10090">mouse</span>
###xml 709 712 <span type="species:ncbi:10116">rat</span>
###xml 854 859 <span type="species:ncbi:10090">mouse</span>
###xml 1049 1052 <span type="species:ncbi:10116">rat</span>
###xml 1058 1063 <span type="species:ncbi:10090">mouse</span>
The following anti-mouse mAbs/secondary reagents were used for flow cytometry: CD45.2-FITC and CD45.2-PerCP-Cy5.5 (30F-11), CD45.1-PE (A20), GR1-PE and GR1-FITC (RB6-8C5), GR1-PE-Cy7 (RB6-8C5), biotinylated I-A/I-E (2G9), NK1.1-APC (PK136), CD4-FITC (RM4-4), biotinylated CD8-alpha (53-6.7), CD11c-PE (HL3), CD11b-FITC (M1/70), SA-APC-Cy7, biotinylated F(ab')2 anti-mouse Ig, Streptavidin-PE, isotype-matched control IgG antibodies (all BD), F4/80-Alexa Fluor 647 (CI:A3-1; Invitrogen), F4/80-Alexa Fluor 488 (BM8; Invitrogen), CD11c-PE-Cy5.5 (418; Invitrogen), CD115-PE (MCA1898; AbD Serotec), T1alpha/Podoplanin/gp36 (Abcam), TRAIL-PE (N2B2; BioLegend), TRAIL R2 (DR5)-PE (118929; R&D Systems), isotype-PE (rat IgG2akappa; BioLegend), antiinfluenza NP (Meridian Life Science, Inc.), annexin V-Alexa Fluor 647, anti-hamster Ig Alexa Fluor 488, and anti-mouse Ig Alexa Fluor 647 (all Invitrogen). 150 mug of low endotoxin/azide-free anti-TRAIL mAb (N2B2; IgG2a; BioLegend) in 150 mul PBS-/- was applied i.p. at days 3, 5, 7, and 9 pi, and 75 mug of rat anti-mouse CCR2 mAb (IgG2b; gift from M. Mack, University of Regensburg, Regensburg, Germany) in 100 mul PBS-/- was applied i.p. at days 0 and 4 pi (42). Respective isotype control IgG Abs (IgG2a [BioLegend] and IgG2b [BD]) were applied at the same concentrations. Propidium iodide was purchased from Sigma-Aldrich.
###end p 51
###begin title 52
###xml 0 4 <span type="species:ncbi:10090">Mice</span>
Mice.
###end title 52
###begin p 53
###xml 166 168 166 168 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib43">43</xref>
###xml 183 184 183 184 <sup xmlns:xlink="http://www.w3.org/1999/xlink">a</sup>
###xml 178 184 178 184 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Ptprc<sup>a</sup></italic>
###xml 11 15 <span type="species:ncbi:10090">mice</span>
###xml 79 83 <span type="species:ncbi:10090">mice</span>
###xml 185 189 <span type="species:ncbi:10090">mice</span>
###xml 350 354 <span type="species:ncbi:10090">mice</span>
###xml 408 412 <span type="species:ncbi:10090">Mice</span>
C57BL/6 WT mice were purchased from Charles River Laboratories. CCR2-deficient mice were generated as described previously and backcrossed to the C57BL/6 background (43). B6.SJL-Ptprca mice expressing the CD45.1 alloantigen (Ly5.1 PTP) on circulating leukocytes (C57BL/6 genetic background) were obtained from The Jackson Laboratory. TRAIL-deficient mice (C57BL/6 genetic background) were a gift from Amgen. Mice were bred under specific pathogen-free conditions. All experiments were approved by the regional council (Regierungsprasidium) of Giessen.
###end p 53
###begin title 54
Treatment protocols.
###end title 54
###begin p 55
###xml 143 146 143 146 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 200 203 199 202 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 300 302 299 301 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib44">44</xref>
###xml 682 683 681 682 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib2">2</xref>
###xml 810 811 809 810 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib4">4</xref>
###xml 1050 1051 1049 1050 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib2">2</xref>
###xml 0 4 <span type="species:ncbi:10090">Mice</span>
###xml 566 570 <span type="species:ncbi:10090">mice</span>
###xml 757 761 <span type="species:ncbi:10090">mice</span>
###xml 1007 1011 <span type="species:ncbi:10090">mice</span>
Mice were intratracheally inoculated with 500 PFU of IV PR/8 (A/PR/8/34; H1N1) or with 50,000 PFU of A/HKx31 (x31; H3N2) diluted in sterile PBS-/- in a total volume of 70 mul or mock-infected with PBS-/- alone, and blood and BAL leukocytes were gained and processed as previously outlined in detail (44). BAL cells were counted with a hemocytometer, and differential cell counts of Pappenheim-stained cytocentrifuge preparations were performed using overall morphological criteria, including differences in cell size and shape of nuclei. Alveolar leakage in treated mice was analyzed by the lung permeability assay by i.v. injection of FITC-labeled albumin as previously described (2). For apoptosis detection, perfused lungs from infected or mock-infected mice were digested as previously outlined in detail (4), washed, and resuspended in FACS buffer (PBS, 7.4% EDTA, and 0.5% FCS). For quantitative analysis of interstitial exudate macrophages, lavaged and perfused lung tissue from WT or CCR2-deficient mice was prepared as previously described (2) and resuspended in FACS buffer.
###end p 55
###begin title 56
Lung virus titers.
###end title 56
###begin p 57
###xml 47 50 47 50 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/+</sup>
###xml 156 157 150 151 <sup xmlns:xlink="http://www.w3.org/1999/xlink">0</sup>
###xml 165 166 159 160 <sup xmlns:xlink="http://www.w3.org/1999/xlink">7</sup>
###xml 208 209 202 203 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 222 223 216 217 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 636 639 628 631 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/+</sup>
###xml 766 771 <span type="species:ncbi:10090">mouse</span>
Lungs were mechanically homogenized in 2 ml PBS+/+ on ice and centrifuged at 4,000 rpm for 10 min at 4degreesC, and supernatants were serially diluted (1:100 to 1:107) in PBS/BA containing 0.2% BSA, 1 mM MgCl2, 0.9 mM CaCl2, 100 U/ml of penicillin, and 0.1 mg/ml of streptomycin. Virus titers were determined by immunohistochemistry on confluent Madin-Darby canine kidney cells in 96-well plates in duplicates. In brief, cells were incubated with 50 mul of homogenate dilution for 1 h at room temperature and covered with 1.5% methylcellulose media containing 2 mug/ml trypsin (PAA) for 72 h. Cells were permeabilized and fixed with PBS+/+/4% PFA/1% Triton X-100, incubated with diluted primary anti-PR/8 nucleoprotein mAb (Biozol) and secondary HRP-conjugated anti-mouse antibody for 45 min each, and stained with an AEC staining kit (Sigma-Aldrich) for 10 min. Foci were counted using a light microscope (DM 2500; Leica).
###end p 57
###begin title 58
Flow cytometry and cell sorting.
###end title 58
###begin p 59
###xml 8 9 8 9 <sup xmlns:xlink="http://www.w3.org/1999/xlink">5</sup>
###xml 124 125 124 125 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 292 293 292 293 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib2">2</xref>
###xml 369 370 369 370 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 656 657 656 657 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib2">2</xref>
###xml 507 511 <span type="species:ncbi:10090">mice</span>
1-5 x 105 PFA-fixed cells were washed in either FACS or annexin V staining buffer (10 mM Hepes, 140 mM NaCl, and 2.5 mM CaCl2), incubated with the respective primary and secondary mAbs, and flow cytometric analysis was performed using a FACSCanto flow cytometer (BD) as previously described (2). Cells stained with primary CCR2 mAb were coupled with biotinylated F(ab')2 anti-Ig for 30 min before a 15-min incubation with Streptavidin-PE. For cell sorting experiments, unfixed blood or BAL cells from eight mice per experiment were incubated with the given mAbs and high purity sorted with a FACSVantage SE flow cytometer as previously outlined in detail (2). Purities of sorted cell population were always >90%.
###end p 59
###begin title 60
ELISA.
###end title 60
###begin p 61
Cytokine levels from BALF were analyzed using commercially available ELISA kits (R&D Systems) according to the manufacturer's instructions. Detection limits were 2 pg/ml for CCL2, 5.1 pg/ml for TNF-alpha, and 12.5 pg/ml for IFN-alpha.
###end p 61
###begin title 62
###xml 24 28 <span type="species:ncbi:10090">mice</span>
Creation of BM chimeric mice.
###end title 62
###begin p 63
###xml 101 104 101 104 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 113 116 113 116 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 153 155 153 155 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib25">25</xref>
###xml 190 193 190 193 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 408 409 408 409 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 123 127 <span type="species:ncbi:10090">mice</span>
###xml 402 406 <span type="species:ncbi:10090">mice</span>
###xml 623 627 <span type="species:ncbi:10090">mice</span>
BM cells were isolated under sterile conditions from the tibias and femurs of WT C57BL/6 or from CCR2-/- or TRAIL-/- donor mice as described previously (25). In some experiments, WT and CCR2-/- BM cells were mixed at a 1:1 ratio before transplantation. As controls for BM engraftment, WT C57BL/6 BM cells (expressing the CD45.2 alloantigen) were transplanted into CD45.1 alloantigen-expressing C57BL/6 mice (n = 2 during each transplantation experiment), and the proportion of CD45.2-positive peripheral blood leukocytes was analyzed by flow cytometry. BM engraftment was 90.5 +/- 2.7% 2 wk after transplantation. Chimeric mice were housed under specific pathogen-free conditions for 14 d before PR/8 infection.
###end p 63
###begin title 64
Preparation of lung tissue sections and TUNEL assay.
###end title 64
###begin p 65
###xml 66 69 65 68 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 211 214 210 213 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
Perfused lungs were carefully lavaged with 400-mul aliquots of PBS-/-/2 mM EDTA to wash out alveolar leukocytes and were thereafter slowly inflated with 1.5 ml of a 1:1 mixture of Tissue-Tek OCT (Sakura) and PBS-/-, removed en bloc, and snap frozen in liquid nitrogen. Lung tissue cryosections were mounted on glass slides and dried overnight at room temperature. Apoptotic cells were stained using the DeadEnd Colorimetric TUNEL system (Promega) according to the manufacturer's instructions. Slides were analyzed with a light microscope (DM 2000; Leica) at the indicated magnification using digital imaging software (Leica).
###end p 65
###begin title 66
RNA isolation and real time RT-PCR.
###end title 66
###begin p 67
###xml 299 300 299 300 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib2">2</xref>
###xml 1090 1102 1084 1088 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#916;&#916;Ct</sup>
RNA from sorted blood or BAL cells was isolated using the RNeasy Micro kit (QIAGEN), whereas RNA from cultured AECs was isolated by PeqGOLD Total RNA kit (PEQLAB) according to the manufacturer's instructions. For cDNA synthesis, reagents and incubation steps were performed as described previously (2). Reactions were performed in an ABI 7900 Sequence Detection System (Applied Biosystem) using SYBR-Green I as fluorogenic probe in 25-mul reactions containing 5 mul cDNA sample, Platinum SYBR Green qPCR SuperMix (Invitrogen), and 45 pmol of forward and reverse primers. The following primer sequences were used: TNF-alpha forward, 5'-CATCTTCTCAAAATTCGAGTGACAA-3', and reverse, 5'-TGGGAGTAGACAAGGTACAACCC-3'; FasL forward, 5'-CCAACCAAAGCCTTAAAGTATCATC-3', and reverse, 5'-AACCCAGTTTCGTTGATCACAA-3'; TRAIL forward, 5'-GAAGACCTCAGAAAGTGGC-3', and reverse, 5'-GACCAGCTCTCCATTCCTA-3'; DR5 forward, 5'-AAGTGTGTCTCCAAAACGG-3', and reverse, 5'-AATGCACAGAGTTCGCACT-3'; and PBGD forward, 5'-GGTACAAGGCTTTCAGCATCG-3', and reverse, 5'-ATGTCCGGTAACGGCGGC-3'. Relative expression was determined by the 2DeltaDeltaCt method.
###end p 67
###begin title 68
AEC isolation and infection.
###end title 68
###begin p 69
###xml 183 184 183 184 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib4">4</xref>
###xml 37 41 <span type="species:ncbi:10090">mice</span>
###xml 79 96 <span type="species:ncbi:11320">influenza A virus</span>
AECs were isolated from untreated WT mice, cultured for 5 d, and infected with influenza A virus at the indicated multiplicity of infection for 8 h as previously described in detail (4).
###end p 69
###begin title 70
Adoptive transfer of PBMC.
###end title 70
###begin p 71
###xml 63 66 63 66 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 75 78 75 78 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 332 333 332 333 <sup xmlns:xlink="http://www.w3.org/1999/xlink">6</sup>
###xml 413 416 412 415 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 79 83 <span type="species:ncbi:10090">mice</span>
###xml 417 421 <span type="species:ncbi:10090">mice</span>
For isolation of PBMCs, whole blood cells gained from WT, TRAIL-/-, or CCR2-/- mice were carefully layered over 3 ml Lympholyte (Biozol). Cells were centrifuged at 1,400 rpm at room temperature for 35 min to separate the mononuclear fraction. The interphase was collected and mononuclear cells were washed twice in RPMI 1640. 2 x 106 MNC in 150 mul RPMI were injected i.v. directly before PR/8 infection into CCR2-/- mice. Purity of MNC was always >90%, as assessed by differential counts on Pappenheim-stained cytocentrifuge preparations.
###end p 71
###begin title 72
Statistical analysis.
###end title 72
###begin p 73
All data are given as the mean +/- SD. For analysis of statistical differences, one-factor ANOVA was applied. Statistical significances between treatment groups were calculated with the SPSS for Windows software program (SPSS, Inc.). Significance was assumed when P values were <0.05.
###end p 73
###begin title 74
Online supplemental material.
###end title 74
###begin p 75
###xml 121 125 <span type="species:ncbi:10090">mice</span>
###xml 244 248 <span type="species:ncbi:10090">mice</span>
Fig. S1 shows the time course of interstitial lung exudate macrophage proportions in PR/8-infected WT and CCR2-deficient mice. Fig. S2 shows the time course of viral titers in lung homogenate of PR/8-infected untreated or anti-TRAIL-treated WT mice. Online supplemental material is available at .
###end p 75
###begin title 76
Supplementary Material
###end title 76
###begin title 77
[Supplemental Material Index]
###end title 77
###begin p 78
The authors wish to thank P. Janssen, M. Lohmeyer, E. Braun, and D. Hensel for excellent technical assistance.
###end p 78
###begin p 79
This work was supported by the German Research Foundation, grant SFB 547 "Cardiopulmonary Vascular System," the Excellence Cluster Cardio-Pulmonary System (ECCPS), the National Network on Community-Acquired Pneumonia (CAPNETZ), and the Clinical Research Group "Infectious Diseases" 01 KI 0770.
###end p 79
###begin p 80
The authors have no conflicting financial interests.
###end p 80

